Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
InChiKey: XFYDIVBRZNQMJC-UHFFFAOYSA-N
Formula: C19H20N4O
Baguley BC
InChi: InChI=1S/C28H30N6OS
LY-303511 amplifies TRAIL-induced apoptosis in tumor cells by enhancing DR5 oligomerization
Erlotinib mesylate Catalog No.:M9562-10 InChiKey: XFYDIVBRZNQMJC-UHFFFAOYSA-NErlotinib is an epidermal growth factor receptor inhibitor (EGFR inhibitor). Erlotinib HCl was approved. Erlotinib binds in a reversible fashion to the adenosine triphosphate (ATP) binding site of the receptor. For the signal to be transmitted, two EGFR molecules need to come together to form a homodimer. These then use the molecule of ATP to trans phosphorylate each other on tyrosine residues, which generates phosphotyrosine residues, recruiting the
US$ 196.38
US$ 88.84
US$ 154.91
US$ 119.12
US$ 109.49
US$ 116.81
US$ 329.00
US$ 107.17
US$ 180.02